SB 364 is a bill relating to a Board of Pharmacy rule governing pharmacists. Based on the available bill caption and legislative status, the measure appears to address regulatory standards or procedures affecting pharmacist practice under the authority of the West Virginia Board of Pharmacy. The full bill text was not available in the provided materials, so the specific rule changes cannot be identified from the record supplied here.
The bill was referred to the Senate Judiciary Committee on January 15, 2026, indicating it was being reviewed for legal and regulatory implications. Because no committee transcript or vote record was provided, the exact scope of the proposal and any amendments are not known from the available context.
Impact
SB 364 would affect state administrative law and the regulatory framework overseen by the West Virginia Board of Pharmacy, potentially changing how pharmacists are licensed, regulated, or permitted to practice under board rules. Any statutory impact would likely be indirect unless the bill amends enabling statutes or validates a specific board rule, but the provided materials do not identify the precise provisions affected.
Sentiment
There is no recorded committee discussion or vote history in the provided materials, so the overall sentiment toward SB 364 cannot be determined from the record supplied. The referral to Judiciary suggests the bill was still in the review process and had not yet generated a documented public debate in the materials provided.
Contention
No specific points of contention are available because the bill text, committee transcript, and voting history were not included. In general, bills involving pharmacy board rules can raise issues such as scope of pharmacist practice, regulatory burden, patient access, and professional oversight, but none of those concerns are documented here for SB 364.
Relating to authorizing the Board of Pharmacy to promulgate a legislative rule relating to the application of waiver of initial licensing fees for certain individuals